HCPCS code Q4128 – Flex HD or AlloPatch HD human acellular dermal matrix

Key takeaways

HCPCS Code Q4128 reports Flex HD or AlloPatch HD, human acellular dermal matrices from MTF Biologics, per square centimeter.

One unit equals 1 cm² of product, and EZDerm is a porcine product billed under Q4136, not Q4128.

For Medicare dates of service from January 1, 2026, bill only the cm² applied on one line, with no JW or JZ modifier.

Q4128 covers the product only, so the application is billed separately with a CPT code matched to wound site and size.

For 2026, CMS pays non-BLA skin substitutes, including Q4128, as incident-to supplies, and only the applied amount is payable.

HCPCS Code Q4128: Quick reference summary

HCPCS Code Q4128 is the Medicare billing code for Flex HD or AlloPatch HD, two human acellular dermal matrices, reported per square centimeter. The table below gives coders its key billing attributes.

Confirm your MAC’s current fee schedule before you submit, as payment rates change every year.

Official code descriptor and product description

The official HCPCS descriptor for Q4128 is “Flex HD, or AlloPatch HD, per square centimeter (add-on, list separately in addition to primary procedure).” Both products are acellular dermal matrices made from donated human skin by MTF Biologics. Processing removes the cells and leaves a collagen scaffold that the patient’s own tissue grows into.

FlexHD is best known from reconstructive surgery, while AlloPatch HD is positioned for wound and soft-tissue repair. Both brands share one code, so either name on the invoice leads to Q4128. According to the Centers for Medicare and Medicaid Services HCPCS overview, Level II codes report products, supplies, and services that CPT does not cover.

Q4128 covers only the product. It does not cover the act of applying the graft. The application procedure is billed separately with a CPT code, which is what the descriptor’s “add-on” wording points to. Submitting Q4128 without a matching procedure code is a frequent billing error.

What Q4128 covers and what it excludes

Medicare coverage of skin substitutes for chronic wounds depends on documented failure of conservative treatment. Indications that MAC policies commonly accept include:

• Diabetic foot ulcers (DFU) with documented failure of standard wound care for the period your MAC sets, commonly four weeks
• Venous leg ulcers (VLU) meeting similar conservative-therapy requirements
• Pressure ulcers of appropriate stage and wound age
• Other chronic full-thickness wounds where the chart documents clinical necessity and prior treatment failure

Non-covered uses include cosmetic procedures, acute traumatic wounds without documented treatment failure, and wound types excluded under the governing LCD. Billing Q4128 for a wound type your MAC’s policy does not list is both a coverage risk and a compliance exposure.

How to calculate units for HCPCS Code Q4128

One unit of HCPCS Code Q4128 equals one square centimeter of Flex HD or AlloPatch HD. For Medicare dates of service from January 1, 2026, bill the applied amount on one claim line, with no wastage modifier. Product opened and discarded is not billable, so the practice absorbs it whenever the sheet is larger than the wound bed.

Report whole units only, and check your payer’s rounding rule for partial square centimeters. Payers may also apply per-encounter quantity limits. Because these limits vary by MAC and commercial payer, verify the maximum billable units before charge entry.

Required modifiers when billing Q4128

For Medicare dates of service from January 1, 2026, Q4128 takes no wastage modifier. CMS now pays non-BLA skin substitutes, including Flex HD and AlloPatch HD, as incident-to supplies. The CMS JW and JZ modifier FAQs (question 9) say JW and JZ are not appropriate for incident-to supplies.

Discarded amounts of those supplies are not payable by Medicare. Some MACs, such as First Coast, reject 2026 claims that carry either modifier.

Dates of service before 2026, or payers that still require them. Medicare required JW on discarded amounts from January 1, 2017, and JZ from July 1, 2023. Under that method, the applied amount went on one line and any discarded amount on a second line with JW. Some commercial payers may still use it, so check each payer’s policy.

For 2026 Medicare claims, bill one Q4128 line for the applied cm² and nothing for the discarded amount. A 10 cm² wound treated from a 15 cm² sheet bills 10 units, and the 5 discarded units are not billable. The diagram below walks one opened sheet through that claim.

Companion CPT codes for skin substitute application

Q4128 is a supply code. It describes what was used, not what was done. Payers expect a matching application code on the same date of service, chosen by anatomical site and total wound surface area.

A diabetic foot ulcer therefore takes 15275 or 15277. A venous leg ulcer under 100 cm² takes 15271, plus 15272 for each additional 25 cm². Infants and children use the 1% of body area thresholds in place of the square-centimeter ones.

Debridement of the same wound before application (CPT 11042–11047, 97597, 97598) is included in 15271–15278 and is not separately reportable under NCCI. Debridement of a different wound or site may be reported with modifier 59 or XS and separate documentation.

Codes commonly confused with Q4128

The Q41xx series holds dozens of skin substitute codes with nearly identical structure. The most damaging mix-up for Q4128 is EZDerm, a porcine product with its own code. The table below lists the codes most often confused with Q4128 and how to tell them apart.

The tissue-source column is the fastest check at charge entry. If the product invoice names a human dermal matrix, confirm the brand before choosing among Q4128, Q4116, and Q4107.

Medicare coverage rules and Local Coverage Determinations

Medicare coverage for HCPCS Code Q4128 is governed by your MAC’s Local Coverage Determination, where it has an active one. The AAPC HCPCS code lookup shows where Q4128 sits in the code set, but the controlling document is always your MAC’s active policy. The LCD in effect on the date of service controls coverage.

Coverage criteria commonly required under MAC policies include:

• Wound present for a minimum period before skin substitute application, commonly four weeks (verify the duration in your MAC’s current LCD)
• Documentation of failed conservative therapy during that period (standard wound care, compression, offloading as appropriate to wound type)
• Wound measurements at the time of each application, with tracings or photographic evidence
• A diagnosis matching a covered ICD-10-CM code (DFU, VLU, or other covered chronic wound type)
• A physician order for the skin substitute product

Payment rules changed too. For 2026, CMS pays non-BLA skin substitutes, including 361 HCT/P products like Flex HD and AlloPatch HD, as incident-to supplies.

Medicare pays them at a single national rate per square centimeter when used with a covered application procedure, in both office and hospital outpatient settings. Only the product applied to the wound is payable. Verify the current rate rather than relying on an older price list.

Some MACs, such as CGS, Novitas, and First Coast, publish a skin substitute LCD. Check whether yours does. CMS and the MACs withdrew the new DFU and VLU skin substitute LCDs on December 24, 2025, before their January 1, 2026 start date. Retrieve the current policy from your MAC’s website, since third-party summaries may cite a superseded version.

Prior authorization requirements for Q4128

Original Medicare does not generally require prior authorization for Q4128, but this varies by jurisdiction and program. CMS’s WISeR prior authorization model, which includes skin substitutes, runs in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington.

Skin substitute review applies only where the MAC has an active skin substitute LCD. That covers the Novitas states (Texas, Oklahoma, and New Jersey) and CGS in Ohio, but not Noridian’s Arizona and Washington. Check your MAC’s announcements before the first application.

Commercial and Medicare Advantage plans are a different matter. Many require prior authorization for skin substitute products. Failing to obtain it before applying Flex HD or AlloPatch HD is a common non-clinical cause of denial in this code range. Record the authorization number in the chart and on the claim before submission.

Place-of-service impact on Q4128 reimbursement

Where you apply Flex HD or AlloPatch HD affects how much Medicare pays. The facility versus non-facility distinction applies to the companion CPT application code, and the setting decides who bills the product. Use the CMS Physician Fee Schedule search to look up the current year’s rate for your setting.

In the hospital outpatient setting, the facility bills Q4128 and is paid separately for the product as an incident-to supply. The physician practice bills only the professional CPT service, at the facility rate. ASCs are also paid for the product as an incident-to supply, so confirm the rate with the facility’s coding team.

Documentation requirements to support Q4128 claims

Many Q4128 denials trace back to the chart rather than the code. The chart must support every element Medicare and commercial payers evaluate during post-payment review. Good medical billing compliance starts with the clinical note, not the claim form.

• Wound measurements: Length, width, and depth in centimeters at each visit. These numbers support the unit count and show wound progression over time.
• Wound tracings or photographs: Commonly required under MAC skin substitute policies. Photographs should include a measurement reference in the image.
• Wound age and etiology: State when the wound was first identified and confirm it meets the minimum duration threshold in your MAC’s current LCD.
• Conservative therapy record: Document each prior treatment, its duration, and the clinical response. This supports the failed-conservative-care requirement.
• Physician order: A signed order naming the product (Flex HD or AlloPatch HD) and the quantity.
• Product size, lot, and tissue ID: Record the sheet size opened, the amount applied and discarded, and the lot or graft ID. Human tissue grafts carry tracking numbers that tie the claim to the product used.
• ICD-10-CM diagnosis codes: Must match a wound type covered under the active LCD. See the ICD-10 pairing section below.

ICD-10 diagnosis codes that support Q4128 medical necessity

The diagnosis code on the Q4128 claim must match a wound type covered under the governing LCD. The wrong ICD-10-CM code generates a denial even when the clinical indication is legitimate. The table below lists common supporting codes, so cross-reference it against the covered-code list in your MAC’s active LCD.

Diabetic foot ulcer codes such as E11.621 also need an L97 code for the ulcer site and depth. Codes describing acute traumatic wounds or cosmetic procedures do not establish medical necessity for Q4128. Using a non-covered diagnosis is both a denial trigger and a compliance risk.

Top reasons Q4128 claims are denied and how to fix them

Q4128 denials tend to repeat. The denial reason codes on these claims cluster around six fixable errors, listed in the table below. Effective denial management for a wound care practice starts with these patterns.

How Pabau catches Q4128 errors before the claim goes out

Coding references describe what Q4128 is, but many Q4128 errors happen at charge entry inside the practice’s own system. Three system-level errors come up again and again:

1. Outdated wastage logic in the charge template: A template built before 2026 may still add JZ or a JW wastage line. Set it to bill only the applied cm² on 2026 Medicare claims, and keep JW and JZ for payers that still require them.
2. Supply code not linked to the application CPT: Some systems let Q4128 go out without a 1527x code. Add a claim edit that requires an application code on any encounter containing Q4128.
3. Units entered as sheets, not square centimeters: One sheet of 16 cm² is 16 units, not 1. Train billers to take units from the product size and amount applied in the visit note.

Pabau, the practice management platform we build, handles the claim side of this workflow. Its claims management software checks each claim for missing or invalid details before it leaves the system. It verifies US eligibility through Claim.MD before the visit and stores prior authorization cases against the booking.

Once a claim is out, Pabau tracks it from pending to paid. A rejected claim is flagged as needing action, with a link to the field that needs correcting. Payments are then matched to invoices from electronic remittance advice files, so short-paid Q4128 lines stand out.

Manage Q4128 claims without the guesswork

Pabau checks every claim for missing or invalid details before it leaves the practice. It then tracks the claim to payment and flags rejections.

Book a demo

Conclusion

Accurate Q4128 billing starts with the product name on the invoice. Flex HD and AlloPatch HD are human dermal matrices. Confusing them with a porcine product such as EZDerm sends the claim to the wrong code. Get the product right, then the applied units, the site-matched CPT code, and the diagnosis follow from the chart.

For 2026, drop JW and JZ from Medicare Q4128 claims, since only the applied amount is payable. Then confirm whether your MAC has an active skin substitute LCD. That check decides the coverage criteria you document against and whether WISeR prior authorization applies.

A practice that bills Q4128 regularly should build this checklist into its charge template, so the system enforces it on every claim. To see how Pabau checks and tracks claims from submission to payment, book a demo with the team.

Continue your research

Need a broader overview of how claims move through the system? Revenue cycle management guide walks through the full claim lifecycle from charge capture to remittance posting.

Getting repeated denials on wound care claims? Clean claim submission standards explains the technical and documentation requirements that determine whether a claim processes without rejection.

Want to understand what clearinghouses do with your HCPCS claims? Medical claims clearinghouse explainer covers how claims are validated and routed before reaching the payer.

Frequently asked questions